{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:59:37Z","timestamp":1778579977453,"version":"3.51.4"},"reference-count":49,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T00:00:00Z","timestamp":1419292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"China National AIDS Programme","award":["131-11-0001-0501"],"award-info":[{"award-number":["131-11-0001-0501"]}]},{"name":"National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis","award":["2012ZX10001-007"],"award-info":[{"award-number":["2012ZX10001-007"]}]},{"name":"Fogarty International Center and the National Institute on Drug Abuse at the US National Institutes of Health","award":["U2RTW06918"],"award-info":[{"award-number":["U2RTW06918"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>The objective of this study was to examine factors that predict antiretroviral therapy (<jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>) access among eligible, <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive methadone maintenance treatment (<jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content>) clients. We also tested the hypothesis that sustained <jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content> participation increases the likelihood of accessing <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A nation\u2010wide cohort study conducted from 1 <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>arch 2004 to 31 <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ecember 2011.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content> clients were followed from the time of their enrolment in <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>hina's national <jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content> programme until their death or the study end date.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Our cohort comprised 7111 <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>\u2010eligible, <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010positive <jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content> clients, 49.2% of whom remained <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>\u2010naive and 50.8% of whom received <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>Demographic variables, drug use history, <jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content> programme participation and <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010related clinical characteristics of study participants who remained naive to <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> and those who accessed <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> were compared by univariate and multivariable analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Predictors of accessing <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> among this cohort included being retained in <jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content> at the time of first meeting <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> eligibility [adjusted odds ratio (<jats:styled-content style=\"fixed-case\">AOR)<\/jats:styled-content>\u2009=\u20091.84, confidence interval (<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>)\u2009=\u20091.54\u20132.21, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001] compared to meeting <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> eligibility before entering <jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">AOR<\/jats:styled-content>\u2009=\u20090.98, <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\u2009=\u20090.80\u20131.21, <jats:italic>P<\/jats:italic>\u2009=\u20090.849) or previously entering <jats:styled-content style=\"fixed-case\">MMT<\/jats:styled-content> and dropping out before meeting <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> eligibility. Additional predictors were <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4 \u2264200 cells\/\u03bcl when <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>\u2010eligibility requirement was first met (<jats:styled-content style=\"fixed-case\">AOR<\/jats:styled-content>\u2009=\u20091.81, CI\u2009=\u20091.61\u20132.05, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001 compared to <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>4\u2009=\u2009201\u2013350 cells\/\u03bcl), and being in a stable partner relationship (married\/cohabitating: <jats:styled-content style=\"fixed-case\">AOR<\/jats:styled-content>\u2009=\u20091.14, <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\u2009=\u20091.01\u20131.28, <jats:italic>P<\/jats:italic>\u2009=\u20090.030).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Retained participation in methadone maintenance treatment increases the likelihood that eligible clients will access antiretroviral therapy. These results highlight the potential benefit of colocalization of methadone maintenance treatment and antiretroviral therapy services in a \u2018one\u2010stop\u2010shop\u2019 model.<\/jats:p><\/jats:sec>","DOI":"10.1111\/add.12782","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T13:18:48Z","timestamp":1419427128000},"page":"40-50","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictors of accessing antiretroviral therapy among <scp>HIV<\/scp>\u2010positive drug users in <scp>C<\/scp>hina's <scp>N<\/scp>ational <scp>M<\/scp>ethadone <scp>M<\/scp>aintenance <scp>T<\/scp>reatment <scp>P<\/scp>rogramme"],"prefix":"10.1111","volume":"110","author":[{"given":"Yan","family":"Zhao","sequence":"first","affiliation":[{"name":"National Center for AIDS\/STD Control and Prevention Chinese Center for Disease Control and Prevention  Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia X.","family":"Shi","sequence":"additional","affiliation":[{"name":"National Center for AIDS\/STD Control and Prevention Chinese Center for Disease Control and Prevention  Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"McGoogan","sequence":"additional","affiliation":[{"name":"National Center for AIDS\/STD Control and Prevention Chinese Center for Disease Control and Prevention  Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keming","family":"Rou","sequence":"additional","affiliation":[{"name":"National Center for AIDS\/STD Control and Prevention Chinese Center for Disease Control and Prevention  Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujie","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Center for AIDS\/STD Control and Prevention Chinese Center for Disease Control and Prevention  Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunyou","family":"Wu","sequence":"additional","affiliation":[{"name":"National Center for AIDS\/STD Control and Prevention Chinese Center for Disease Control and Prevention  Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,12,23]]},"reference":[{"key":"e_1_2_6_2_1","volume-title":"UNAIDS Report on the Global AIDS Epidemic 2010","author":"Joint United Nations Programme on HIV\/AIDS","year":"2010"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61311-2"},{"key":"e_1_2_6_4_1","volume-title":"Annual Report on Drug Control in China 2011","author":"National Narcotics Control Commission","year":"2011"},{"key":"e_1_2_6_5_1","volume-title":"2011 Estimates for the HIV\/AIDS Epidemic in China","author":"Ministry of Health, Joint United Nations Programme on HIV\/AIDS, World Health Organization","year":"2011"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60232-2"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181958530"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-010-0059-z"},{"key":"e_1_2_6_9_1","first-page":"196","article-title":"Methadone maintenance treatment as an HIV prevention strategy: a research update [in Chinese]","volume":"17","author":"Cao X.","year":"2011","journal-title":"Chin J AIDS STD"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq215"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq210"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61097-0"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02323.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00963.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.02905.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2009.05.003"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00582.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1086\/503905"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000304704.71917.64"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.11.004"},{"key":"e_1_2_6_21_1","volume-title":"Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for A Public Health Approach. 2010 Revision","author":"World Health Organization","year":"2010"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70097-4"},{"key":"e_1_2_6_23_1","volume-title":"China Free Antiretroviral Therapy Manual [in Chinese]","author":"Ministry of Health Working Group on Clinical AIDS Treatment","year":"2012"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq213"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyp233"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000304710.10036.2b"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2003.00130.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.05.002"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2006.12.014"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60832-X"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02249.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.02.003"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00701.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2011.608420"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2011.630359"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000423"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60315-8"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00006"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13802-0"},{"key":"e_1_2_6_40_1","first-page":"1488","article-title":"Engaging HIV\u2010infected patients in antiretroviral therapy services: CD4 cell count testing after HIV diagnosis from 2005 to 2009 in Yunnan and Guangxi, China","volume":"124","author":"Zhang Y.","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-005-9028-8"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2006.22.715"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32834bcb36"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00390-3"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-004-3063-7"},{"key":"e_1_2_6_46_1","volume-title":"Technical Guide for Countries to Set Targets for Universal Access to HIV Prevention, Treatment and Care for Injecting Drug Users","author":"World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV\/AIDS","year":"2009"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.6.544"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.08.003"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2011.648602"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-4-2"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12782","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.12782","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/add.12782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T03:35:02Z","timestamp":1695699302000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.12782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,23]]},"references-count":49,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1111\/add.12782"],"URL":"https:\/\/doi.org\/10.1111\/add.12782","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,23]]},"assertion":[{"value":"2012-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-09-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}